[go: up one dir, main page]

ATE529417T1 - 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält - Google Patents

3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält

Info

Publication number
ATE529417T1
ATE529417T1 AT08766040T AT08766040T ATE529417T1 AT E529417 T1 ATE529417 T1 AT E529417T1 AT 08766040 T AT08766040 T AT 08766040T AT 08766040 T AT08766040 T AT 08766040T AT E529417 T1 ATE529417 T1 AT E529417T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
mucus secretion
trimethoxyflavone
derivatives
composition containing
Prior art date
Application number
AT08766040T
Other languages
English (en)
Inventor
Seul-Min Choi
Kyung-Koo Kang
Dong-Sung Kim
Jeong-Hoon Kim
Byoung-Ok Ahn
Moo-Hi Yoo
Mi-Jeong Seo
Ju-Mi Kim
Yong-Duck Kim
Sun-Woo Jang
Yong-Sung Shon
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Application granted granted Critical
Publication of ATE529417T1 publication Critical patent/ATE529417T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08766040T 2007-06-07 2008-06-02 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält ATE529417T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020070055427A KR100930467B1 (ko) 2007-06-07 2007-06-07 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
PCT/KR2008/003078 WO2008150085A2 (en) 2007-06-07 2008-06-02 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
ATE529417T1 true ATE529417T1 (de) 2011-11-15

Family

ID=40094296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08766040T ATE529417T1 (de) 2007-06-07 2008-06-02 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält

Country Status (14)

Country Link
US (1) US8203011B2 (de)
EP (1) EP2170857B1 (de)
JP (1) JP5295230B2 (de)
KR (1) KR100930467B1 (de)
CN (1) CN101679341B (de)
AT (1) ATE529417T1 (de)
AU (1) AU2008260829B2 (de)
BR (1) BRPI0812494A2 (de)
CA (1) CA2689136C (de)
DK (1) DK2170857T3 (de)
ES (1) ES2375184T3 (de)
MX (1) MX2009013062A (de)
PT (1) PT2170857E (de)
WO (1) WO2008150085A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009018350A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Pyrone analog compositions and methods
WO2010129138A2 (en) * 2009-04-27 2010-11-11 Limerick Biopharma Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
CN102796066B (zh) * 2012-08-31 2014-09-03 云南民族大学 一种黄酮类化合物及其制备方法与应用
CN103059005B (zh) * 2012-11-22 2015-04-22 中南民族大学 白杨素酰胺衍生物及其医药用途
CN107921022B (zh) * 2015-08-24 2021-06-01 澳门大学 用于治疗干眼病和斯耶格伦氏综合征的组合物
CN107373745B (zh) * 2017-07-28 2020-04-03 云南中烟工业有限责任公司 一种防止烟草料液腐败变质的添加剂及其应用
KR102040810B1 (ko) * 2018-01-31 2019-11-05 인제대학교 산학협력단 알파-휴물렌을 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물
KR102685191B1 (ko) * 2021-07-26 2024-07-15 동아제약 주식회사 레코플라본 또는 이의 염을 포함하는 피부개선용 화장료 조성물
EP4342453A1 (de) * 2021-08-05 2024-03-27 GL Pharmtech Corp. Augentropfenzusammensetzung zur behandlung des trockenen auges mit recofflavon und verfahren zur herstellung davon
WO2023014117A1 (ko) * 2021-08-05 2023-02-09 지엘팜텍주식회사 안구건조증 치료를 위한 레코플라본 함유 점안 조성물 및 이의 제조방법
KR102356603B1 (ko) * 2021-08-05 2022-02-08 지엘팜텍주식회사 안구건조증 치료를 위한 레코플라본 함유 점안 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
DE3628590A1 (de) * 1986-08-22 1988-02-25 Musikon Gmbh Raumeinheit fuer die aufnahme und/oder wiedergabe von akustischen signalen
US5006550A (en) * 1989-12-29 1991-04-09 Allergan, Inc. Chroman esters of phenols and benzoic acids having retinoid-like activity
KR100447918B1 (ko) * 1996-07-25 2005-09-28 동아제약주식회사 대장을포함한위장관보호작용을갖는플라본및플라바논화합물
FR2753969B1 (fr) * 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3957795B2 (ja) * 1996-10-04 2007-08-15 興和株式会社 フラボン誘導体及びこれを含有する医薬
JPH11279062A (ja) * 1998-01-30 1999-10-12 Fujisawa Pharmaceut Co Ltd 眼科用剤
KR100327621B1 (ko) 1999-09-22 2002-03-15 유충식 7-카르복시메틸옥시-3',4',5-트리메톡시플라본의 제조방법
JP2001233775A (ja) * 2000-02-28 2001-08-28 Cci Corp 涙液分泌促進剤
KR20050024121A (ko) * 2003-09-04 2005-03-10 동아제약주식회사 7-카르복시메틸옥시-3',4',5-트리메톡시 플라본.일수화물, 이의 제조방법 및 용도
EP1856085B1 (de) * 2005-03-11 2015-07-08 Howard Florey Institute Pty Ltd Flavonoidverbindungen und verwendungen davon
PL2444079T3 (pl) * 2005-05-17 2017-07-31 Sarcode Bioscience Inc. Kompozycje i sposoby leczenia chorób oczu

Also Published As

Publication number Publication date
KR100930467B1 (ko) 2009-12-08
CA2689136C (en) 2012-11-13
EP2170857A4 (de) 2010-06-23
ES2375184T3 (es) 2012-02-27
WO2008150085A3 (en) 2009-02-26
AU2008260829B2 (en) 2012-11-08
PT2170857E (pt) 2011-12-12
AU2008260829A1 (en) 2008-12-11
KR20080107542A (ko) 2008-12-11
JP5295230B2 (ja) 2013-09-18
MX2009013062A (es) 2010-01-18
CN101679341A (zh) 2010-03-24
BRPI0812494A2 (pt) 2015-06-16
CA2689136A1 (en) 2008-12-11
EP2170857A2 (de) 2010-04-07
DK2170857T3 (da) 2011-12-05
WO2008150085A2 (en) 2008-12-11
US20100130448A1 (en) 2010-05-27
US8203011B2 (en) 2012-06-19
JP2010529112A (ja) 2010-08-26
EP2170857B1 (de) 2011-10-19
CN101679341B (zh) 2012-06-06

Similar Documents

Publication Publication Date Title
ATE529417T1 (de) 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
DE602006006308D1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
BRPI0520588B8 (pt) uso de composições farmacêuticas para o tratamento de doenças do ouvido interno
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
WO2003096989A3 (en) Anti tubercular drug: compositions and methods
ATE412402T1 (de) Ophthalmische suspension aus einem ophthalmischen arzneimittel, einem poloxamin und glykol- tonizitätsanpassenden mittel, verwendung der zusammensetzung zur herstellung eines medikaments zur behandlung von augenerkrankungen
EP4344743A3 (de) Heterocyclische flavonderivate, zusammensetzungen und damit in zusammenhang stehende verfahren
AR063538A1 (es) Tratamiento de la enfermedad de parkinson
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
WO2009032843A3 (en) Deuterated ethambutols and their use
EA200602092A1 (ru) Способ и композиция для лечения ринита
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
WO2007023072A3 (en) Use of ambroxol for the treatment of rhinovirus infections
ATE464052T1 (de) Neue pharmazeutische verwendungen von staurosporin-derivaten
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
EP1262197A3 (de) Kombinationstherapie zur Behandlung von Schlafstörungen, Schlaflosigkeit inbegriffen
MXPA05014143A (es) Derivados de cumarina para el tratamiento de trastornos oftalmicos.
RU2010154623A (ru) Производные 1-аминоалкилциклогексана для лечения расстройств сна
PT1307192E (pt) Candesartan para tratamento da enxaqueca
BR0316123A (pt) Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico
MX2008011178A (es) Agente profilàctico o terapèutico para enfermedad oftàlmica alèrgica o enfermedad nasal alèrgica, que comprende derivado tricìclico de triazolobenzacepina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2170857

Country of ref document: EP